Circulating Tumor Cells as a Predictive Biomarker in Resectable Lung Cancer: A Systematic Review and Meta-Analysis.
Durgesh WankhedeSandeep GroverPaul HofmanPublished in: Cancers (2022)
Our meta-analysis revealed that CTC is a promising predictive biomarker for stratifying survival outcomes in patients with early-stage NSCLC. However, future studies are required to validate these findings and standardize detection methods.
Keyphrases
- circulating tumor cells
- early stage
- systematic review
- case control
- circulating tumor
- small cell lung cancer
- meta analyses
- current status
- single cell
- advanced non small cell lung cancer
- locally advanced
- randomized controlled trial
- real time pcr
- sentinel lymph node
- squamous cell carcinoma
- liver metastases
- brain metastases